Empresa Newron Pharmaceuticals SpA CBOE EUROPE EQUITIES
Acciones
0QOI
IT0004147952
Farmacéuticos
Precio de cierre
Otros sitios de cotización
|
||
- CHF | - |
|
Resumen de negocios
Ventas por actividad
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100,0
%
| 6 | 100,0 % | 9 | 100,0 % | +43,85 % |
Ventas por región
CHF en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Italy & United States
100,0
%
| 6 | 100,0 % | 9 | 100,0 % | +43,85 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Stefan Weber
CEO | Chief Executive Officer | 60 | 15/05/12 |
Luca Benatti
FOU | Founder | 63 | 01/01/98 |
Roberto Galli
DFI | Director of Finance/CFO | - | 01/01/02 |
Filippo Moriggia
COO | Chief Operating Officer | - | 01/11/16 |
Ravi Anand
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/05 |
Laura Faravelli
PRN | Corporate Officer/Principal | - | 01/01/19 |
Dennis Dionne
PRN | Corporate Officer/Principal | - | 01/01/15 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 78 | 01/01/08 | |
Luca Benatti
FOU | Founder | 63 | 01/01/98 |
Ulrich Köstlin
CHM | Chairman | 71 | 01/01/13 |
Stefan Weber
CEO | Chief Executive Officer | 60 | 15/05/12 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 18 631 834 | 16 874 414 ( 90,57 %) | 0 | 90,57 % |
Información de la empresa
![Dirección Newron Pharmaceuticals SpA(0QOI)](https://cdn.zonebourse.com/static/address/16417982.png)
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,99 % | 95,18 mil M | |
-4,34 % | 37,55 mil M | |
-10,41 % | 33,75 mil M | |
+75,79 % | 28,2 mil M | |
-14,61 % | 15,63 mil M | |
-3,46 % | 13,63 mil M | |
-12,31 % | 11,5 mil M | |
+184,77 % | 10,81 mil M | |
-54,13 % | 9233,36 M |
- Bolsa de valores
- Acciones
- Acción NWRN
- Acción 0QOI
- Empresa Newron Pharmaceuticals SpA